Cart
sales@molnova.com
4-Methoxybenzoic acid
CAS No. 100-09-4
4-Methoxybenzoic acid( p-Anisic acid | NSC 32742 )
Catalog No. M17742 CAS No. 100-09-4
4-Methoxybenzoic acid could be used as raw material in cosmetic and dermatologic products and/or aroma components in foodstuffs, it has antiinflammatory and antimicrobial activities.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 100MG | 41 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name4-Methoxybenzoic acid
-
NoteResearch use only, not for human use.
-
Brief Description4-Methoxybenzoic acid could be used as raw material in cosmetic and dermatologic products and/or aroma components in foodstuffs, it has antiinflammatory and antimicrobial activities.
-
Descriptionp-Anisic acid, also known as 4-methoxybenzoic acid or draconic acid, is one of the isomers of anisic acid. The term "anisic acid" often refers to this form specifically. p-Anisic acid is found naturally in anise.
-
In Vitro——
-
In Vivo——
-
Synonymsp-Anisic acid | NSC 32742
-
PathwayAngiogenesis
-
TargetCDK
-
Recptorantibacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number100-09-4
-
Formula Weight152.14
-
Molecular FormulaC8H8O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (657.25 mM)
-
SMILESCOC1=CC=C(C=C1)C(=O)O
-
Chemical NameBenzoic acid, 4-methoxy-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
SR-4835
SR-4835 is a highly selective dual inhibitor of CDK12 and CDK13(CDK12: IC50=99 nM Kd=98 nM; CDK13: Kd=4.9 nM) which disables triple-negative breast cancer (TNBC) cells.
-
LEE011
LEE011 is an orally available, and highly specific CDK4/6 inhibitor. Phase 3.
-
LY2857785
LY2857785 is a potenrt, reversible and ATP-competitive CDK9 inhibitor with IC50 of 11 nM, also inhibits CDK8 (IC50=16 nM) and weakly inhibits CSK7 (IC50=246 nM).
